Finding 372601 (2023-003)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-03-06
Audit: 293672
Auditor: Mahoney

AI Summary

  • Core Issue: Credit card charges for former employees lacked proper documentation and approval.
  • Impacted Requirements: Internal controls over credit card transactions were not enforced, risking reimbursement for non-organization related costs.
  • Recommended Follow-Up: Reinstate and enforce the credit card policy, educate employees, and review current procedures for improvements.

Finding Text

2023-003 Lack of Support for Credit Card Charges for Former Employees Significant Deficiency Criteria – Management is responsible for establishing and maintaining internal controls over organizational credit cards in order to safeguard the assets of the Organization. A key element of internal control is the review and approval of supporting documentation submitted by employees for credit card transactions. Condition – The Organization designed a control which required documentation, review and approval for credit card charges. However, this control was not enforced and credit card charges were paid by the Organization without any support showing the costs related to the Organization. Cause – During the transition between Executive Directors, the Interim Executive Director waived this requirement to increase morale. Effect – The Organization may have reimbursed costs that were not for the benefit of the Organization. Recommendation – We recommend the Organization reinstate the policy and educate its employees regarding Organization credit card charges, and then make sure to enforce the policy. The Organization should consider reviewing and updating their policies and procedures. Auditee's comments and response – Management agrees with the finding. Management has re-instated the credit card receipt policy and has begun to enforce this policy. Management is also taking action to review current policies and procedures surrounding employee credit cards and reimbursements. Responsible party for corrective action: Laura Straw, Finance Director Repeat Finding: No

Categories

Cash Management Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 372584 2023-001
    Material Weakness Repeat
  • 372585 2023-001
    Material Weakness Repeat
  • 372586 2023-001
    Material Weakness Repeat
  • 372587 2023-001
    Material Weakness Repeat
  • 372588 2023-001
    Material Weakness Repeat
  • 372589 2023-001
    Material Weakness Repeat
  • 372590 2023-001
    Material Weakness Repeat
  • 372591 2023-001
    Material Weakness Repeat
  • 372592 2023-002
    Significant Deficiency
  • 372593 2023-002
    Significant Deficiency
  • 372594 2023-002
    Significant Deficiency
  • 372595 2023-002
    Significant Deficiency
  • 372596 2023-002
    Significant Deficiency
  • 372597 2023-002
    Significant Deficiency
  • 372598 2023-002
    Significant Deficiency
  • 372599 2023-002
    Significant Deficiency
  • 372600 2023-003
    Significant Deficiency
  • 372602 2023-003
    Significant Deficiency
  • 372603 2023-003
    Significant Deficiency
  • 372604 2023-003
    Significant Deficiency
  • 372605 2023-003
    Significant Deficiency
  • 372606 2023-003
    Significant Deficiency
  • 372607 2023-003
    Significant Deficiency
  • 372608 2023-004
    Material Weakness Repeat
  • 372609 2023-004
    Material Weakness Repeat
  • 372610 2023-004
    Material Weakness Repeat
  • 372611 2023-004
    Material Weakness Repeat
  • 372612 2023-004
    Material Weakness Repeat
  • 372613 2023-004
    Material Weakness Repeat
  • 372614 2023-004
    Material Weakness Repeat
  • 372615 2023-004
    Material Weakness Repeat
  • 372616 2023-005
    Significant Deficiency Repeat
  • 372617 2023-005
    Significant Deficiency Repeat
  • 372618 2023-005
    Significant Deficiency Repeat
  • 372619 2023-005
    Significant Deficiency Repeat
  • 372620 2023-005
    Significant Deficiency Repeat
  • 372621 2023-006
    Significant Deficiency
  • 372622 2023-006
    Significant Deficiency
  • 372623 2023-006
    Significant Deficiency
  • 372624 2023-006
    Significant Deficiency
  • 372625 2023-006
    Significant Deficiency
  • 949026 2023-001
    Material Weakness Repeat
  • 949027 2023-001
    Material Weakness Repeat
  • 949028 2023-001
    Material Weakness Repeat
  • 949029 2023-001
    Material Weakness Repeat
  • 949030 2023-001
    Material Weakness Repeat
  • 949031 2023-001
    Material Weakness Repeat
  • 949032 2023-001
    Material Weakness Repeat
  • 949033 2023-001
    Material Weakness Repeat
  • 949034 2023-002
    Significant Deficiency
  • 949035 2023-002
    Significant Deficiency
  • 949036 2023-002
    Significant Deficiency
  • 949037 2023-002
    Significant Deficiency
  • 949038 2023-002
    Significant Deficiency
  • 949039 2023-002
    Significant Deficiency
  • 949040 2023-002
    Significant Deficiency
  • 949041 2023-002
    Significant Deficiency
  • 949042 2023-003
    Significant Deficiency
  • 949043 2023-003
    Significant Deficiency
  • 949044 2023-003
    Significant Deficiency
  • 949045 2023-003
    Significant Deficiency
  • 949046 2023-003
    Significant Deficiency
  • 949047 2023-003
    Significant Deficiency
  • 949048 2023-003
    Significant Deficiency
  • 949049 2023-003
    Significant Deficiency
  • 949050 2023-004
    Material Weakness Repeat
  • 949051 2023-004
    Material Weakness Repeat
  • 949052 2023-004
    Material Weakness Repeat
  • 949053 2023-004
    Material Weakness Repeat
  • 949054 2023-004
    Material Weakness Repeat
  • 949055 2023-004
    Material Weakness Repeat
  • 949056 2023-004
    Material Weakness Repeat
  • 949057 2023-004
    Material Weakness Repeat
  • 949058 2023-005
    Significant Deficiency Repeat
  • 949059 2023-005
    Significant Deficiency Repeat
  • 949060 2023-005
    Significant Deficiency Repeat
  • 949061 2023-005
    Significant Deficiency Repeat
  • 949062 2023-005
    Significant Deficiency Repeat
  • 949063 2023-006
    Significant Deficiency
  • 949064 2023-006
    Significant Deficiency
  • 949065 2023-006
    Significant Deficiency
  • 949066 2023-006
    Significant Deficiency
  • 949067 2023-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.267 Continuum of Care Program $326,522
14.231 Emergency Solutions Grant Program $118,642